The University of Chicago Header Logo

Ari Rosenberg

TitleAssociate Professor
InstitutionUniversity of Chicago
DepartmentMedicine-Hematology and Oncology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Swiecicki PL, Hanna GJ, Geiger JL, Fujisawa T, Haigentz M, Honma Y, Bruce JY, Tanaka K, Muro K, Bhateja P, Kaplan J, Liu S, Gorla S, Wozniak M, Dillon R, Hamed S, Meng C, Chaney MF, Rosenberg AJ. Enfortumab Vedotin plus Pembrolizumab as First-line Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Results from EV-202 Cohort 9. Clin Cancer Res. 2026 Aug 14; 32(16):3531-3539. PMID: 42084607; PMCID: PMC13473864.
      Citations:    Fields:    
    2. Singh A, Korzinkin M, Sarkisova V, Vergasova E, Rosenberg AJ, Suresh K, Mishra V, Miao Y, Shen L, Smolik J, Veviorskiy A, Pun FW, Cheng X, Wing C, Pinto J, Low CM, Lingen MW, Rooper L, Pearson AT, Vokes EE, Liu X, London N, Zhavoronkov A, Agrawal N, Izumchenko E. Comprehensive multi-omic dissection and AI-prioritized target identification in inverted papilloma-associated sinonasal squamous cell carcinoma. NPJ Precis Oncol. 2026 Jul 10. PMID: 42432132.
      Citations:    
    3. Burtness B, Rosenberg AJ, Calderon B, Lim SM, Yang MH, Li SH, Kadowaki S, Swiecicki PL, Geiger JL, Ince W, Hahn D, Guo Y, Adkins D, Metcalf R, Ahn MJ, Sukari A, Braña I, Keam B, Tanaka H, Sheth S, Oliva M, Lyu X, Curtin JC, Toyoizumi K, Xie J, Wade M, Diorio B, Kapoor A, Yilmaz E, Baig M, Kim P, Verheijen RB, Shah S, Harrington KJ, OrigAMI-4 Cohort 1 Investigators. Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study. J Clin Oncol. 2026 Aug 20; 44(24):2271-2277. PMID: 42218660; PMCID: PMC13489780.
      Citations:    Fields:    
    4. Daste A, Le X, Makkouk A, Patel M, Le Tourneau C, Perets R, Popovtzer A, Ochsenreither S, Haderlein M, Oliva M, Sukari A, Hong J, Blaney M, Ramathal C, McDevitt M, Rosenberg AJ. Phase 1b study of ABBV-368, tilsotolimod, budigalimab, and nab-paclitaxel in patients with recurrent/metastatic head and neck squamous cell carcinoma. J Immunother Cancer. 2026 Apr 09; 14(4). PMID: 41956545; PMCID: PMC13084855.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    5. Pearson AT, Muzaffar J, Kirtane K, Bellile E, Suresh K, Rosenberg AJ, Worden F, Chung CH, Vokes E, Brenner JC, Bhangale A, McHugh J, Warner K, Nor F, Nor JE, Innes K, Zhai Y, Fu T, Swiecicki PL. MDM2 Inhibition with Alrizomadlin (APG-115) in TP53 wild-type salivary gland cancers: a phase I clinical trial. Nat Commun. 2026 Mar 19; 17(1). PMID: 41857036; PMCID: PMC13168462.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    6. Guo W, Luan J, Huang X, Leon D, Gang S, Nicholson B, Bertacchi B, Bolotin D, Lingen MW, Pearson AT, Izumchenko E, Rosenberg AJ, Agrawal N, Vokes EE, Punyawatthananukool S, Narumiya S, Gunzer M, Ballesteros I, Hidalgo A, Miao Y. Tumor-initiating stem cells fine-tune the plasticity of neutrophils to sculpt a protective niche. Cancer Cell. 2026 Jan 12; 44(1):94-111.e11. PMID: 41349542; PMCID: PMC12700342.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    7. Harrington KJ, Rosenberg AJ, Yang MH, Geiger JL, Oliva M, Ahn MJ, Lim SM, Ince W, Bhatia A, Sheth S, Keam B, Metcalf R, Curtin JC, Toyoizumi K, Wade M, Yilmaz E, Kim P, Verheijen RB, Shah S, Baig M, Swiecicki PL. Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 study. Oral Oncol. 2025 Dec; 171:107791. PMID: 41275660.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    8. Bossi P, Kiyota N, Mesía R, Rosenberg AJ, Martino R, Fazer-Posorske C, Salmio S, Schroeder A, Yom SS. Adverse event profiles and management of cisplatin-based chemoradiotherapy in locally advanced head and neck squamous cell carcinoma: a systematic review. Oral Oncol. 2025 Oct; 169:107596. PMID: 40857970.
      Citations: 2     Fields:    Translation:Humans
    9. Rosenberg AJ, Izumchenko E, Juloori A, Katipally R, Cursio J, Choudhury N, Gooi Z, Blair E, Chin J, Hasina R, Vannier A, Starus A, Jones FS, Gramiccioni EL, Miao Y, Haraf DJ, Vokes EE, Pearson AT, Agrawal N, Rosenberg AJ, Izumchenko E, Juloori A, Katipally R, Cursio J, Choudhury N, Gooi Z, Blair E, Chin J, Hasina R, Vannier A, Starus A, Jones FS, Gramiccioni EL, Miao Y, Haraf DJ, Vokes EE, Pearson AT, Agrawal N. Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus-Associated Oropharyngeal Cancer. Clin Cancer Res. 2025 Aug 01; 31(15):3150-3159. PMID: 40423530; PMCID: PMC12332768.
      Citations: 2     Fields:    Translation:HumansCells
    10. Eickelschulte S, Starus A, Murray DH, Keyser KA, Schauer O, Guellert S, Gramiccioni EL, Fredebohm J, Jones F, Quon H, Kut C, Cao Y, Fakhry C, Seiwert T, Miao Y, Lingen MW, Pearson AT, Vokes EE, Rosenberg AJ, Agrawal N, Izumchenko E. Analytical and clinical performance validation of HPV-SEQ, a novel NGS-based liquid biopsy platform for detection and quantification of human papilloma virus circulating tumor DNA. Oral Oncol. 2025 Aug; 167:107445. PMID: 40578243.
      Citations: 1     Fields:    Translation:HumansCells
    11. Rosenberg AJ, Vokes EE. Harnessing Immunotherapy in Curative-Intent Treatment of Head and Neck Cancer. N Engl J Med. 2025 Jul 03; 393(1):85-87. PMID: 40532147.
      Citations:    Fields:    
    12. Zandberg DP, Allred JB, Rosenberg AJ, Kaczmar JM, Swiecicki P, Julian RA, Poklepovic AS, Bauman JR, Phan MD, Saba NF, Rivera E, Rowland K, Davar D, Cordes J, Ho AL, Zhang M, Berg SA, Munster PN, Schwartz GK. Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma. J Clin Oncol. 2025 07 20; 43(21):2398-2408. PMID: 40448574; PMCID: PMC12677393.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    13. Rosenberg AJ, Juloori A, Jelinek MJ, Agrawal N, Cursio JF, Cipriani N, Lingen MW, Izumchenko E, Katipally R, Chin J, Ginat D, Pasternak-Wise O, Gooi Z, Blair E, Pearson AT, Haraf DJ, Vokes EE. Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized Clinical Trial. JAMA Oncol. 2025 May 01; 11(5):492-501. PMID: 40048190; PMCID: PMC11886870.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    14. Manikandan DB, Jagadeeshan S, Mathukkada S, Shareb RA, Prasad M, Belsamma LVS, Marripati D, Erez N, Wainer M, Geva A, Raviv D, Allon I, Morris LG, Su GH, Wang H, Rosenberg AJ, Kessler L, Burrows F, Elkabets M. Anti-PD1 prolongs the response of PI3K and farnesyl transferase inhibition in HRAS- and PIK3CA-mutant head and neck cancers. Neoplasia. 2025 05; 63:101157. PMID: 40117718; PMCID: PMC11978339.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    15. Swiecicki PL, Yilmaz E, Rosenberg AJ, Fujisawa T, Bruce JY, Meng C, Wozniak M, Zhao Y, Mihm M, Kaplan J, Gorla S, Geiger JL. Reply to: Enfortumab Vedotin: A Promising Therapy for Head and Neck Cancer With Potential Links to Human Papillomavirus. J Clin Oncol. 2025 May; 43(13):1611-1612. PMID: 39970368.
      Citations:    Fields:    
    16. Mishra V, Singh A, Korzinkin M, Cheng X, Wing C, Sarkisova V, Koppayi AL, Pogorelskaya A, Glushchenko O, Sundaresan M, Thodima V, Carter J, Ito K, Scherle P, Trzcinska A, Ozerov I, Vokes EE, Cole G, Pun FW, Shen L, Miao Y, Pearson AT, Lingen MW, Ruggeri B, Rosenberg AJ, Zhavoronkov A, Agrawal N, Izumchenko E. PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands. J Exp Clin Cancer Res. 2025 Jan 11; 44(1):11. PMID: 39794830; PMCID: PMC11724466.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    17. Rosenberg AJ, Agrawal N, Juloori A, Cursio J, Gooi Z, Blair E, Chin J, Ginat D, Pasternak-Wise O, Hasina R, Starus A, Jones FS, Izumchenko E, MacCracken E, Wolk R, Cipriani N, Lingen MW, Pearson AT, Seiwert TY, Haraf DJ, Vokes EE. Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled Trial. JAMA Oncol. 2024 Jul 01; 10(7):923-931. PMID: 38842838; PMCID: PMC11157444.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    18. Rosenberg AJ, Perez CA, Guo W, de Oliveira Novaes JM, da Silva Reis KFO, McGarrah PW, Price KAR. Breaking Ground in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Novel Therapies Beyond PD-L1 Immunotherapy. Am Soc Clin Oncol Educ Book. 2024 Jun; 44(3):e433330. PMID: 38718318.
      Citations: 9     Fields:    Translation:Humans
    19. Cyberski TF, Singh A, Korzinkin M, Mishra V, Pun F, Shen L, Wing C, Cheng X, Baird B, Miao Y, Elkabets M, Kochanny S, Guo W, Dyer E, Pearson AT, Juloori A, Lingen M, Cole G, Zhavoronkov A, Agrawal N, Izumchenko E, Rosenberg AJ. Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer. NPJ Precis Oncol. 2024 May 23; 8(1):114. PMID: 38783041; PMCID: PMC11116544.
      Citations: 10     
    20. Jagadeeshan S, Suryamohan K, Shin N, Mathukkada S, Boyko A, Melikhova D, Tsareva A, Yunusova L, Pravdivtseva E, Stupichev D, Shaposhnikov K, Peterson A, Bednyagin L, Shugaev-Mendosa E, Kessler L, Burrows F, Ho AL, Agrawal N, Pearson AT, Izumchenko E, Cole G, Elkabets M, Rosenberg AJ. Evolutionary dynamics of tipifarnib in HRAS mutated head and neck squamous cell carcinoma. Oral Oncol. 2024 02; 149:106688. PMID: 38219706; PMCID: PMC11309563.
      Citations: 4     Fields:    Translation:HumansCells
    21. Pun FW, Leung GHD, Leung HW, Rice J, Schmauck-Medina T, Lautrup S, Long X, Liu BHM, Wong CW, Ozerov IV, Aliper A, Ren F, Rosenberg AJ, Agrawal N, Izumchenko E, Fang EF, Zhavoronkov A. A comprehensive AI-driven analysis of large-scale omic datasets reveals novel dual-purpose targets for the treatment of cancer and aging. Aging Cell. 2023 12; 22(12):e14017. PMID: 37888486; PMCID: PMC10726874.
      Citations: 19     Fields:    Translation:HumansAnimals
    22. Jagadeeshan S, Novoplansky OZ, Cohen O, Kurth I, Hess J, Rosenberg AJ, Grandis JR, Elkabets M. New insights into RAS in head and neck cancer. Biochim Biophys Acta Rev Cancer. 2023 11; 1878(6):188963. PMID: 37619805; PMCID: PMC11815531.
      Citations: 5     Fields:    Translation:HumansCells
    23. Rosenberg AJ, Liao CY, Karrison T, de Souza JA, Worden FP, Libao B, Krzyzanowska MK, Hayes DN, Winquist E, Saloura V, Prescott K, Villaflor VM, Seiwert TY, Schechter RB, Stadler WM, Cohen EEW, Vokes EE. A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer. Ann Oncol. 2023 08; 34(8):714-722. PMID: 37182801; PMCID: PMC10696593.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    24. Jagadeeshan S, Prasad M, Badarni M, Ben-Lulu T, Liju VB, Mathukkada S, Saunders C, Shnerb AB, Zorea J, Yegodayev KM, Wainer M, Vtorov L, Allon I, Cohen O, Gausdal G, Friedmann-Morvinski D, Cheong SC, Ho AL, Rosenberg AJ, Kessler L, Burrows F, Kong D, Grandis JR, Gutkind JS, Elkabets M. Mutated HRAS Activates YAP1-AXL Signaling to Drive Metastasis of Head and Neck Cancer. Cancer Res. 2023 04 04; 83(7):1031-1047. PMID: 36753744; PMCID: PMC10073343.
      Citations: 16     Fields:    Translation:HumansCells
    25. Auger S, Davis A, Rosenberg AJ. Recommendations for Care of Survivors of Head and Neck Cancer. JAMA. 2022 10 25; 328(16):1637-1638. PMID: 36201185.
      Citations: 5     Fields:    Translation:Humans
    26. Ginat DT, Juloori A, Vivar OI, Farber LA, Gooi Z, Rosenberg AJ. Imaging Features of Intratumoral Injection of NBTXR3 for Head and Neck Squamous Cell Carcinoma Lymph Node Metastases. Diagnostics (Basel). 2022 Sep 05; 12(9). PMID: 36140557; PMCID: PMC9498208.
      Citations: 5     
    27. Goldberg M, Manzi A, Birdi A, Laporte B, Conway P, Cantin S, Mishra V, Singh A, Pearson AT, Goldberg ER, Goldberger S, Flaum B, Hasina R, London NR, Gallia GL, Bettegowda C, Young S, Sandulache V, Melville J, Shum J, O'Neill SE, Aydin E, Zhavoronkov A, Vidal A, Soto A, Alonso MJ, Rosenberg AJ, Lingen MW, D'Cruz A, Agrawal N, Izumchenko E. A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer. Nat Commun. 2022 08 17; 13(1):4829. PMID: 35977936; PMCID: PMC9385702.
      Citations: 29     Fields:    Translation:Animals
    28. Rosenberg AJ, Agrawal N, Pearson AT, Gooi Z, Blair E, Portugal L, Cursio JF, Juloori A, Chin J, Rouse K, Villaflor VM, Seiwert TY, Izumchenko E, Lingen MW, Haraf DJ, Vokes EE. Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma. Br J Cancer. 2022 11; 127(8):1497-1506. PMID: 35945244; PMCID: PMC9553920.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    29. Ferrarotto R, Mishra V, Herz E, Yaacov A, Solomon O, Rauch R, Mondshine A, Motin M, Leibovich-Rivkin T, Davis M, Kaye J, Weber CR, Shen L, Pearson AT, Rosenberg AJ, Chen X, Singh A, Aster JC, Agrawal N, Izumchenko E. AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signaling. Cell Death Dis. 2022 08 05; 13(8):678. PMID: 35931701; PMCID: PMC9355983.
      Citations: 30     Fields:    Translation:HumansCells
    30. Hara JH, Gutiontov SI, Uddin S, Rosenberg AJ, Pearson AT, Gooi Z, Blair EA, Agrawal N, Vokes EE, Ginat DT, Haraf DJ, Juloori A. Characterizing Lymph Node Burden With Elective Unilateral Neck Irradiation in Human Papillomavirus-Positive Tonsil Squamous Cell Carcinoma: Defining the Upper Limits. Cureus. 2022 Jul; 14(7):e27521. PMID: 36060366; PMCID: PMC9424785.
      Citations:    
    31. Dolezal JM, Rosenberg AJ. Induction Chemotherapy in Low-Risk HPV+ Oropharyngeal Cancer. Curr Treat Options Oncol. 2022 01; 23(1):54-67. PMID: 35171457; PMCID: PMC9619415.
      Citations: 3     Fields:    Translation:HumansCells
    32. Rosenberg AJ, Izumchenko E, Pearson A, Gooi Z, Blair E, Karrison T, Juloori A, Ginat D, Cipriani N, Lingen M, Sloane H, Edelstein DL, Keyser K, Fredebohm J, Holtrup F, Jones FS, Haraf D, Agrawal N, Vokes EE. Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment. BMC Cancer. 2022 Jan 03; 22(1):17. PMID: 34980038; PMCID: PMC8722316.
      Citations: 8     Fields:    Translation:HumansCellsCTClinical Trials
    33. Mishra V, Singh A, Chen X, Rosenberg AJ, Pearson AT, Zhavoronkov A, Savage PA, Lingen MW, Agrawal N, Izumchenko E. Application of liquid biopsy as multi-functional biomarkers in head and neck cancer. Br J Cancer. 2022 02; 126(3):361-370. PMID: 34876674; PMCID: PMC8810877.
      Citations: 34     Fields:    Translation:HumansAnimalsCells
    34. Luu R, Valdebenito S, Scemes E, Cibelli A, Spray DC, Rovegno M, Tichauer J, Cottignies-Calamarte A, Rosenberg A, Capron C, Belouzard S, Dubuisson J, Annane D, de la Grandmaison GL, Cramer-Bordé E, Bomsel M, Eugenin E. Pannexin-1 channel opening is critical for COVID-19 pathogenesis. iScience. 2021 Dec 17; 24(12):103478. PMID: 34841222; PMCID: PMC8603863.
      Citations: 30     
    35. Rosenberg AJ, Agrawal N, Pearson A, Gooi Z, Blair E, Cursio J, Juloori A, Ginat D, Howard A, Chin J, Kochanny S, Foster C, Cipriani N, Lingen M, Izumchenko E, Seiwert TY, Haraf D, Vokes EE. Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience. Oral Oncol. 2021 11; 122:105566. PMID: 34662771; PMCID: PMC9295443.
      Citations: 17     Fields:    Translation:HumansCellsCTClinical Trials
    36. Ghantous Y, Omar M, Broner EC, Agrawal N, Pearson AT, Rosenberg AJ, Mishra V, Singh A, El-Naaj IA, Savage PA, Sidransky D, Marchionni L, Izumchenko E. A robust and interpretable gene signature for predicting the lymph node status of primary T1/T2 oral cavity squamous cell carcinoma. Int J Cancer. 2022 02 01; 150(3):450-460. PMID: 34569064; PMCID: PMC8760163.
      Citations: 7     Fields:    Translation:HumansCells
    37. Broner EC, Trujillo JA, Korzinkin M, Subbannayya T, Agrawal N, Ozerov IV, Zhavoronkov A, Rooper L, Kotlov N, Shen L, Pearson AT, Rosenberg AJ, Savage PA, Mishra V, Chatterjee A, Sidransky D, Izumchenko E. Doublecortin-Like Kinase 1 (DCLK1) Is a Novel NOTCH Pathway Signaling Regulator in Head and Neck Squamous Cell Carcinoma. Front Oncol. 2021; 11:677051. PMID: 34336664; PMCID: PMC8323482.
      Citations: 15     
    38. Rosenberg AJ. Multimodality Therapy for Locoregional Nasopharyngeal Carcinoma-A Decision Tool for Treatment Optimization. JAMA Netw Open. 2020 12 01; 3(12):e2030672. PMID: 33306112.
      Citations: 1     Fields:    Translation:Humans
    39. Rosenberg AJ, Vokes EE. Optimizing Treatment De-Escalation in Head and Neck Cancer: Current and Future Perspectives. Oncologist. 2021 01; 26(1):40-48. PMID: 32864799; PMCID: PMC7794179.
      Citations: 57     Fields:    Translation:HumansCells
    40. Price KAR, Nichols AC, Shen CJ, Rammal A, Lang P, Palma DA, Rosenberg AJ, Chera BS, Agrawal N. Novel Strategies to Effectively De-escalate Curative-Intent Therapy for Patients With HPV-Associated Oropharyngeal Cancer: Current and Future Directions. Am Soc Clin Oncol Educ Book. 2020 Mar; 40:1-13. PMID: 32213088.
      Citations: 18     Fields:    Translation:Humans
    41. Rosenberg AJ, Rademaker A, Hochster HS, Ryan T, Hensing T, Shankaran V, Baddi L, Mahalingam D, Mulcahy MF, Benson AB. Docetaxel, Oxaliplatin, and 5-Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Study with Long-Term Follow-Up. Oncologist. 2019 08; 24(8):1039-e642. PMID: 31138725; PMCID: PMC6693711.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    42. Rosenberg AJ, Wainwright DA, Rademaker A, Galvez C, Genet M, Zhai L, Lauing KL, Mulcahy MF, Hayes JP, Odell DD, Horbinski C, Komanduri S, Tetreault MP, Kim KA, Villaflor VM. Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancer. Oncotarget. 2018 May 04; 9(34):23482-23493. PMID: 29805749; PMCID: PMC5955099.
      Citations: 19     Fields:    
    43. Rosenberg A, Agulnik M. Epithelioid Hemangioendothelioma: Update on Diagnosis and Treatment. Curr Treat Options Oncol. 2018 03 15; 19(4):19. PMID: 29546487.
      Citations: 74     Fields:    Translation:Humans
    44. Rosenberg A, Mahalingam D. Immunotherapy in pancreatic adenocarcinoma-overcoming barriers to response. J Gastrointest Oncol. 2018 Feb; 9(1):143-159. PMID: 29564181; PMCID: PMC5848027.
      Citations: 34     
    45. Chae YK, Arya A, Chiec L, Shah H, Rosenberg A, Patel S, Raparia K, Choi J, Wainwright DA, Villaflor V, Cristofanilli M, Giles F. Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the optimal patients for matched therapy? Oncotarget. 2017 Nov 21; 8(59):100863-100898. PMID: 29246028; PMCID: PMC5725070.
      Citations: 13     Fields:    
    46. Rosenberg A, Selounski V, Wardak H, Han J, Gowhari M, Hassan J, Jain S, Molokie RE, Gordeuk VR, Saraf SL. Utility of the revised cardiac risk index for predicting postsurgical morbidity in Hb SC and Hb Sß+-thalassemia sickle cell disease. Am J Hematol. 2016 06; 91(6):E316-7. PMID: 26994407; PMCID: PMC5377925.
      Citations: 1     Fields:    Translation:Humans
    Rosenberg's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (145)
    Explore
    _
    Co-Authors (32)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _